Market Place
Sourcing Support
All News #Library
Rare Diseases
Biomarin Bet On Amicus To Ease Voxzogo`s Decline. Will It Work?
12 Feb 2026 //
BIOSPACE
Biomarin to Buy Amicus for $4.8 B in Rare Disease Bet
19 Dec 2025 //
PRESS RELEASE
Rare Disease Clinical Progress Boosts Long-Term Revenue Potential
07 Aug 2025 //
PR NEWSWIRE
Dimerix, Amicus Therapeutics License Agreement for DMX-200 in US
30 Apr 2025 //
GLOBENEWSWIRE
The FDA blamed COVID for delaying its review of Amicus` drug
31 Oct 2022 //
FIERCEPHARMA
Amicus rare disease data build hope for approval
03 Oct 2019 //
BIOPHARMADIVE
Orphan drugs from Biogen and Amicus win UK Prix Galien
17 Nov 2018 //
PM LIVE
Amicus`s Launches Healing Beyond Disease™ Initiatives to Change People’s Lives
27 Feb 2018 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.